ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 79 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $8,457 | +34.9% | 10,664 | +32.7% | 0.00% | – |
| Q3 2023 | $6,269 | -57.8% | 8,037 | -50.0% | 0.00% | – |
| Q2 2023 | $14,868 | +114269.2% | 16,074 | +31.0% | 0.00% | – |
| Q1 2023 | $13 | +8.3% | 12,272 | +53.6% | 0.00% | – |
| Q4 2022 | $12 | -100.0% | 7,988 | -73.3% | 0.00% | -100.0% |
| Q3 2022 | $32,000 | -36.0% | 29,870 | +1.7% | 0.00% | 0.0% |
| Q2 2022 | $50,000 | +400.0% | 29,384 | +523.5% | 0.00% | – |
| Q1 2022 | $10,000 | -54.5% | 4,713 | -20.5% | 0.00% | – |
| Q4 2021 | $22,000 | -53.2% | 5,928 | -34.7% | 0.00% | -100.0% |
| Q3 2021 | $47,000 | +161.1% | 9,079 | +114.1% | 0.00% | – |
| Q2 2021 | $18,000 | -40.0% | 4,240 | -25.3% | 0.00% | -100.0% |
| Q1 2021 | $30,000 | +114.3% | 5,675 | +111.5% | 0.00% | – |
| Q4 2020 | $14,000 | -46.2% | 2,683 | -72.0% | 0.00% | -100.0% |
| Q1 2020 | $26,000 | – | 9,591 | +5820.4% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 162 | -99.2% | 0.00% | -100.0% |
| Q3 2019 | $32,000 | – | 21,472 | +21372.0% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 100 | -98.4% | 0.00% | -100.0% |
| Q1 2019 | $27,000 | +285.7% | 6,390 | +1188.3% | 0.00% | +100.0% |
| Q3 2018 | $7,000 | -69.6% | 496 | -74.7% | 0.00% | 0.0% |
| Q2 2018 | $23,000 | -37.8% | 1,961 | -41.0% | 0.00% | -66.7% |
| Q1 2018 | $37,000 | +15.6% | 3,321 | -31.1% | 0.00% | -25.0% |
| Q4 2017 | $32,000 | +100.0% | 4,822 | +31.6% | 0.00% | +100.0% |
| Q2 2017 | $16,000 | +1500.0% | 3,663 | +1171.9% | 0.00% | – |
| Q4 2016 | $1,000 | -90.9% | 288 | -81.3% | 0.00% | -100.0% |
| Q3 2016 | $11,000 | +450.0% | 1,537 | +638.9% | 0.00% | – |
| Q2 2016 | $2,000 | – | 208 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 5,555,461 | $4,405,481 | 2.16% |
| MPM BioImpact LLC | 5,095,912 | $4,041,058 | 0.94% |
| NEA Management Company, LLC | 17,079,778 | $13,544,624 | 0.90% |
| Syncona Portfolio Ltd | 1,377,294 | $1,092,194 | 0.69% |
| PFM Health Sciences, LP | 10,423,135 | $8,265,546 | 0.50% |
| TANG CAPITAL MANAGEMENT LLC | 4,387,238 | $3,479,080 | 0.32% |
| Long Focus Capital Management, LLC | 12,086,915 | $9,584,924 | 0.32% |
| Matrix Capital Management Company, LP | 38,974,185 | $30,906,529 | 0.32% |
| Acuitas Investments, LLC | 479,789 | $380,473 | 0.20% |
| Key Client Fiduciary Advisors, LLC | 336,620 | $266,940 | 0.16% |